BioInvent will present new data from BI-1206 (triplet) and BI-1808 (T-cell lymphoma) at ash. BI-1808 is fully enrolled (n=21) with a readout expected at ASH on 7 December. New data, as of August, show deepening responses.
LÄS MER
